https://scholars.lib.ntu.edu.tw/handle/123456789/530165
標題: | Phenotypes of bronchopulmonary dysplasia | 作者: | Wang S.-H. PO-NIEN TSAO |
關鍵字: | Bronchopulmonary dysplasia; Corticosteroids; Hyperoxia; Inflammation; Metabolomics; Phenotype; Preterm | 公開日期: | 2020 | 出版社: | MDPI AG | 卷: | 21 | 期: | 17 | 起(迄)頁: | 1-20 | 來源出版物: | International Journal of Molecular Sciences | 摘要: | Bronchopulmonary dysplasia (BPD) is the most common chronic morbidity in preterm infants. In the absence of effective interventions, BPD is currently a major therapeutic challenge. Several risk factors are known for this multifactorial disease that results in disrupted lung development. Inflammation plays an important role and leads to persistent airway and pulmonary vascular disease. Since corticosteroids are potent anti-inflammatory agents, postnatal corticosteroids have been used widely for BPD prevention and treatment. However, the clinical responses vary to a great degree across individuals, and steroid-related complications remain major concerns. Emerging studies on the molecular mechanism of lung alveolarization during inflammatory stress will elucidate the complicated pathway and help discover novel therapeutic targets. Moreover, with the advances in metabolomics, there are new opportunities to identify biomarkers for early diagnosis and prognosis prediction of BPD. Pharmacometabolomics is another novel field aiming to identify the metabolomic changes before and after a specific drug treatment. Through this “metabolic signature,” a more precise treatment may be developed, thereby avoiding unnecessary drug exposure in non-responders. In the future, more clinical, genetic, and translational studies would be required to improve the classification of BPD phenotypes and achieve individualized care to enhance the respiratory outcomes in preterm infants. ? 2020 by the authors. Licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090018643&doi=10.3390%2fijms21176112&partnerID=40&md5=11fcaf357ba32534942cf8de872cee66 https://scholars.lib.ntu.edu.tw/handle/123456789/530165 |
ISSN: | 1661-6596 | DOI: | 10.3390/ijms21176112 | SDG/關鍵字: | corticosteroid; dexamethasone; hydrocortisone; biological marker; corticosteroid; angiogenesis; human; hyperoxia; immunological tolerance; lung blood vessel; lung development; lung dysplasia; lung epithelium; lung structure; metabolomics; pharmacometabolomics; phenotype; pneumonia; Review; risk factor; screening; early diagnosis; lung dysplasia; metabolism; personalized medicine; phenotype; translational research; Adrenal Cortex Hormones; Biomarkers; Bronchopulmonary Dysplasia; Early Diagnosis; Humans; Metabolomics; Phenotype; Precision Medicine; Translational Medical Research |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。